Us Congress 2025-2026 Regular Session

Us Congress House Bill HB1620 Compare Versions

Only one version of the bill is available at this time.

Old	New	Differences
1	1	I
2	2	119THCONGRESS
3	3	1
4	4	STSESSION H. R. 1620
5	5	To facilitate the development of treatments for cancer, and for other purposes.
6	6	IN THE HOUSE OF REPRESENTATIVES
7	7	FEBRUARY26, 2025
8	8	Ms. M
9	9	ATSUI(for herself, Mr. BILIRAKIS, Mr. THOMPSONof California, Mr.
10	10	G
11	11	RIJALVA, Mr. BACON, Ms. WASSERMANSCHULTZ, Mr. LANDSMAN, Mr.
12	12	H
13	13	IMES, Ms. TLAIB, Ms. SEWELL, and Mr. DAVISof North Carolina) in-
14	14	troduced the following bill; which was referred to the Committee on En-
15	15	ergy and Commerce, and in addition to the Committee on Ways and
16	16	Means, for a period to be subsequently determined by the Speaker, in
17	17	each case for consideration of such provisions as fall within the jurisdic-
18	18	tion of the committee concerned
19	19	A BILL
20	20	To facilitate the development of treatments for cancer, and
21	21	for other purposes.
22	22	Be it enacted by the Senate and House of Representa-1
23	23	tives of the United States of America in Congress assembled, 2
24	24	SECTION 1. SHORT TITLE. 3
25	25	This Act may be cited as the ‘‘Finn Sawyer Access 4
26	26	to Cancer Testing Act’’. 5
27	27	SEC. 2. COVERAGE OF CANCER DIAGNOSTIC AND LABORA-6
28	28	TORY TESTS. 7
29	29	(a) M
30	30	EDICARE.— 8
31	31	VerDate Sep 11 2014 04:53 Mar 14, 2025 Jkt 059200 PO 00000 Frm 00001 Fmt 6652 Sfmt 6201 E:\BILLS\H1620.IH H1620
32	32	kjohnson on DSK7ZCZBW3PROD with $$_JOB 2
33	33	•HR 1620 IH
34	34	(1) COVERAGE.—Section 1861 of the Social Se-1
35	35	curity Act (42 U.S.C. 1395x) is amended— 2
36	36	(A) in subsection (s)(2)— 3
37	37	(i) in subparagraph (JJ), by adding 4
38	38	‘‘and’’ at the end; and 5
39	39	(ii) by adding at the end the following 6
40	40	new subparagraph: 7
41	41	‘‘(KK) cancer diagnostic and laboratory tests 8
42	42	(as defined in subsection (nnn)) furnished on or 9
43	43	after the date that is 6 months after the date of the 10
44	44	enactment of this subparagraph.’’; and 11
45	45	(B) by adding at the end the following new 12
46	46	subsection: 13
47	47	‘‘(nnn) C
48	48	ANCERDIAGNOSTIC AND LABORATORY 14
49	49	T
50	50	ESTS.— 15
51	51	‘‘(1) I
52	52	N GENERAL.—The term ‘cancer diag-16
53	53	nostic and laboratory tests’ means— 17
54	54	‘‘(A) microarray analysis, DNA sequenc-18
55	55	ing, RNA sequencing, whole-exome sequencing, 19
56	56	and other forms of next-generation sequencing 20
57	57	furnished and reported by a clinical laboratory 21
58	58	(as defined in section 353(a) of the Public 22
59	59	Health Service Act); and 23
60	60	VerDate Sep 11 2014 04:53 Mar 14, 2025 Jkt 059200 PO 00000 Frm 00002 Fmt 6652 Sfmt 6201 E:\BILLS\H1620.IH H1620
61	61	kjohnson on DSK7ZCZBW3PROD with $$_JOB 3
62	62	•HR 1620 IH
63	63	‘‘(B) explanation and interpretation of any 1
64	64	analysis or sequencing described in subpara-2
65	65	graph (A); 3
66	66	furnished to an individual diagnosed with cancer. 4
67	67	‘‘(2) F
68	68	REQUENCY.—When an individual test as 5
69	69	described in paragraph (1) reports out the same ge-6
70	70	netic content, it may only be furnished with respect 7
71	71	to an individual diagnosed with a cancer— 8
72	72	‘‘(A) once upon the diagnosis of such can-9
73	73	cer; 10
74	74	‘‘(B) once upon any recurrence of such 11
75	75	cancer; and 12
76	76	‘‘(C) as necessary for purposes of planning 13
77	77	treatment or monitoring the progression of such 14
78	78	cancer or the response of such cancer to treat-15
79	79	ment.’’. 16
80	80	(2) P
81	81	AYMENT.—Section 1833 of the Social Se-17
82	82	curity Act (42 U.S.C. 1395l) is amended— 18
83	83	(A) in subsection (a)(1)— 19
84	84	(i) by striking ‘‘and’’ before ‘‘(HH)’’; 20
85	85	and 21
86	86	(ii) by inserting the following before 22
87	87	the semicolon: ‘‘, and (II) with respect to 23
88	88	cancer diagnostic and laboratory tests (as 24
89	89	defined in section 1861(nnn)), the amount 25
90	90	VerDate Sep 11 2014 04:53 Mar 14, 2025 Jkt 059200 PO 00000 Frm 00003 Fmt 6652 Sfmt 6201 E:\BILLS\H1620.IH H1620
91	91	kjohnson on DSK7ZCZBW3PROD with $$_JOB 4
92	92	•HR 1620 IH
93	93	paid shall be an amount equal to 80 per-1
94	94	cent (or 100 percent, in the case of such 2
95	95	tests for which payment is made on an as-3
96	96	signment-related basis) of the lesser of the 4
97	97	actual charge for the test or the amount 5
98	98	that would have been determined for such 6
99	99	test under section 1834A had such test 7
100	100	been a clinical diagnostic laboratory test;’’; 8
101	101	and 9
102	102	(B) in subsection (b)— 10
103	103	(i) by striking ‘‘, and (13)’’ and in-11
104	104	serting ‘‘(13)’’; and 12
105	105	(ii) by striking ‘‘1861(n).’’ and insert-13
106	106	ing ‘‘section 1861(n), and (14) such de-14
107	107	ductible shall not apply with respect to 15
108	108	cancer diagnostic and laboratory tests (as 16
109	109	defined in section 1861(nnn))’’. 17
110	110	(3) E
111	111	XCLUSION MODIFICATION .—Section 18
112	112	1862(a)(1) of the Social Security Act (42 U.S.C. 19
113	113	1395y(a)(1)) is amended— 20
114	114	(A) in subparagraph (O), by striking 21
115	115	‘‘and’’ at the end; 22
116	116	(B) in subparagraph (P), by striking the 23
117	117	semicolon and inserting ‘‘, and’’; and 24
118	118	VerDate Sep 11 2014 04:53 Mar 14, 2025 Jkt 059200 PO 00000 Frm 00004 Fmt 6652 Sfmt 6201 E:\BILLS\H1620.IH H1620
119	119	kjohnson on DSK7ZCZBW3PROD with $$_JOB 5
120	120	•HR 1620 IH
121	121	(C) by adding at the end the following new 1
122	122	subparagraph: 2
123	123	‘‘(Q) in the case of cancer diagnostic and lab-3
124	124	oratory tests (as defined in section 1861(nnn)), 4
125	125	which are performed more frequently than is covered 5
126	126	under such section;’’. 6
127	127	(b) M
128	128	EDICAID.— 7
129	129	(1) I
130	130	NCLUSION AS MEDICAL ASSISTANCE .—Sec-8
131	131	tion 1905(a) of the Social Security Act (42 U.S.C. 9
132	132	1396d(a)) is amended— 10
133	133	(A) in paragraph (31), by striking ‘‘and’’ 11
134	134	at the end; 12
135	135	(B) by redesignating paragraph (32) as 13
136	136	paragraph (33); and 14
137	137	(C) by inserting after paragraph (31) the 15
138	138	following new paragraph: 16
139	139	‘‘(32) cancer diagnostic and laboratory tests (as 17
140	140	defined in section 1861(nnn)); and’’. 18
141	141	(2) M
142	142	ANDATORY COVERAGE .—Section 19
143	143	1902(a)(10)(A) of such Act is amended, in the mat-20
144	144	ter preceding clause (i), by striking ‘‘and (30)’’ and 21
145	145	inserting ‘‘(30), and (32)’’. 22
146	146	(3) I
147	147	NCLUSION IN BENCHMARK COVERAGE .— 23
148	148	Section 1937(b)(5) of such Act is amended by in-24
149	149	serting before the period at the end the following: ‘‘, 25
150	150	VerDate Sep 11 2014 04:53 Mar 14, 2025 Jkt 059200 PO 00000 Frm 00005 Fmt 6652 Sfmt 6201 E:\BILLS\H1620.IH H1620
151	151	kjohnson on DSK7ZCZBW3PROD with $$_JOB 6
152	152	•HR 1620 IH
153	153	and beginning January 1, 2027, coverage of cancer 1
154	154	diagnostic and laboratory tests (as defined in section 2
155	155	1861(nnn))’’. 3
156	156	(4) E
157	157	FFECTIVE DATE.— 4
158	158	(A) I
159	159	N GENERAL.—The amendments made 5
160	160	by this section shall apply with respect to items 6
161	161	and services furnished on or after January 1, 7
162	162	2027. 8
163	163	(B) E
164	164	XEMPTION FOR STATE LEGISLA -9
165	165	TION.—In the case of a State plan under title 10
166	166	XIX of the Social Security Act (42 U.S.C. 1396 11
167	167	et seq.), or waiver of such plan, that the Sec-12
168	168	retary of Health and Human Services deter-13
169	169	mines requires State legislation in order for the 14
170	170	respective plan to meet any requirement im-15
171	171	posed by amendments made by this section, the 16
172	172	respective plan shall not be regarded as failing 17
173	173	to comply with the requirements of such title 18
174	174	solely on the basis of its failure to meet such 19
175	175	an additional requirement before the first day 20
176	176	of the first calendar quarter beginning after the 21
177	177	close of the first regular session of the State 22
178	178	legislature that begins after the date of the en-23
179	179	actment of this Act. For purposes of the pre-24
180	180	vious sentence, in the case of a State that has 25
181	181	VerDate Sep 11 2014 04:53 Mar 14, 2025 Jkt 059200 PO 00000 Frm 00006 Fmt 6652 Sfmt 6201 E:\BILLS\H1620.IH H1620
182	182	kjohnson on DSK7ZCZBW3PROD with $$_JOB 7
183	183	•HR 1620 IH
184	184	a 2-year legislative session, each year of the ses-1
185	185	sion shall be considered to be a separate regular 2
186	186	session of the State legislature. 3
187	187	(c) CHIP.—Section 2103(c) of the Social Security 4
188	188	Act (42 U.S.C. 1397cc(c)), as amended by section 5
189	189	11405(b)(1) of Public Law 117–169, is amended by add-6
190	190	ing at the end the following new paragraph: 7
191	191	‘‘(13) C
192	192	OVERAGE OF CANCER DIAGNOSTIC AND 8
193	193	LABORATORY TESTS.—Regardless of the type of cov-9
194	194	erage elected by a State under subsection (a), begin-10
195	195	ning January 1, 2027, child health assistance pro-11
196	196	vided under such coverage for targeted low-income 12
197	197	children and, in the case that the State elects to pro-13
198	198	vide pregnancy-related assistance under such cov-14
199	199	erage pursuant to section 2112, such pregnancy-re-15
200	200	lated assistance for targeted low-income pregnant 16
201	201	women (as defined in section 2112(d)), shall include 17
202	202	coverage of cancer diagnostic and laboratory tests 18
203	203	(as defined in section 1861(nnn)).’’. 19
204	204	SEC. 3. EDUCATION AND AWARENESS PROGRAM ON 20
205	205	GENOMIC TESTING. 21
206	206	(a) I
207	207	NGENERAL.—The Secretary of Health and 22
208	208	Human Services, in coordination with the Director of the 23
209	209	National Human Genome Research Institute, shall carry 24
210	210	out an education and awareness program for physicians 25
211	211	VerDate Sep 11 2014 04:53 Mar 14, 2025 Jkt 059200 PO 00000 Frm 00007 Fmt 6652 Sfmt 6201 E:\BILLS\H1620.IH H1620
212	212	kjohnson on DSK7ZCZBW3PROD with $$_JOB 8
213	213	•HR 1620 IH
214	214	and the general public on what genomic testing is, how 1
215	215	can be used, and the role of genetic counselors. 2
216	216	(b) C
217	217	ANCER ANDMOLECULARDIAGNOSTICS.—The 3
218	218	education and awareness program under subsection (a) 4
219	219	shall encourage the inclusion in graduate medical edu-5
220	220	cation and continuing medical education (including for 6
221	221	specialty oncology services) of education and training on 7
222	222	the importance of molecular diagnostics at diagnosis and 8
223	223	reoccurrence of cancer to detect mutations. 9
224	224	Æ
225	225	VerDate Sep 11 2014 04:53 Mar 14, 2025 Jkt 059200 PO 00000 Frm 00008 Fmt 6652 Sfmt 6301 E:\BILLS\H1620.IH H1620
226	226	kjohnson on DSK7ZCZBW3PROD with $$_JOB